Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Study of ASP1707 A Randomized, Placebo-Controlled, Double-Blind, Parallel Group Phase 2a Study of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)

NCT02884635 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT02884635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02884635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Study of ASP1707 A Randomized, Placebo-Controlled, Double-Blind, Parallel Group Phase 2a Study of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2
Overall status
Completed
Start date
September 16, 2016
Completion date
October 25, 2017
Enrollment
72 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis